RDIF, Hetero to produce over 100 million doses of Sputnik V vaccine in India

According to the second interim data analysis by Gamaleya Center and RDIF on November 24, the Sputnik V vaccine demonstrated a 91.4% efficacy rate in the evaluation carried out 28 days after administering the first dose.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/368uKZ4